Naturalnano Inc (NNAND) 0.2451 $NNAND NaturalNano

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Naturalnano Inc (NNAND) 0.2451 $NNAND

NaturalNano Receives New Orders from Fiabila S.A. a World Leader in the Manufacture of Cosmetic Products; Reports Record Sales for Q1
ACCESSWIRE - Wed Jun 24, 7:31AM CDT
ROCHESTER, NY / ACCESSWIRE / June 24, 2015 / NaturalNano, Inc. (PINKSHEETS: NNAN) (www.naturalnano.com) announced today that it received new increased orders for its proprietary Halloysite Nanotubes (HNT) from Fiabila S.A., a world leader in the manufacture of nail polish and nail care products. HNT is a key component and differentiator for a number of the Fiabila Product lines. The recent orders for HNT helped lift NNAN's Q1 sales for the current year to a record high of $115,085 and substantial increase vs Q1 2014. The Company reported total sales for all of 2014 were $193,606.

Cancer Cell Targeting Breakthrough Using NaturalNano's Halloysite Modified with Surfactants
ACCESSWIRE - Thu Apr 16, 9:00AM CDT
ROCHESTER, NY / ACCESSWIRE / April 16, 2015 / NaturalNano, Inc. (PINKSHEETS:NNAN) (www.naturalnano.com) announced today a new breakthrough for Cancer targeting using our NaturalNano Halloysite modified with surfactants.

NaturalNano Extends Its Long Term Commercial Relationship with Fiabila S.A. a World Leader in the Manufacture of Cosmetic Products
ACCESSWIRE - Tue Feb 17, 9:46AM CST
ROCHESTER, NY / ACCESSWIRE / February 17, 2015 / NaturalNano, Inc. (OTCPK: NNAN) (www.naturalnano.com) announced today a three year extension of its long term relationship with Fiabila S.A., a world leader in the manufacture of nail polish and nail care products. NNAN supplies Fiabila with its proprietary Halloysite Nanotubes (HNT) as a key component for a number of the Fiabila Product lines.

NaturalNano's ViralProtec Division Ships Ebola Personal Protective Equipment to Hospitals in North America
ACCESSWIRE - Mon Dec 01, 8:01AM CST
ROCHESTER, NY / ACCESSWIRE / December 1, 2014 / NaturalNano, Inc. (PINKSHEETS: NNAN) (www.naturalnano.com) announced that its ViralProtec Division (www.viralprotec.com) has successfully executed and shipped Personal Protective Equipment orders to multiple hospitals in North America.

NaturalNano Establishes ViralProtec Division to Supply Personal Protective Equipment for Caregivers in Fight Against Ebola and Other Infectious Diseases
Marketwired - Tue Oct 28, 7:55AM CDT
NaturalNano, Inc. (PINKSHEETS: NNAN) (www.naturalnano.com) announced today the formation of its ViralProtec Division (www.viralprotec.com) to service the growing demand for Personal Protective Equipment (PPE). The recent public concern and publicity surrounding the increased risk to caregivers and other responders created by the Ebola virus as well as other public health concerns has raised awareness of the need for additional precautionary steps for those dealing with these issues.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exploring Murphy Oil Inc.'s Price-to-Earnings Insights

Updated Category News Views 152

Understanding Murphy Oil Inc.'s Recent Market Performance Currently, Murphy Oil Inc. (NYSE: MUR) shares are valued at $30.88, exhibiting a minor rise of 0.06% in today's trading session. Observing the stock’s journey over the last month, we've seen a significant increase of 6.77%. However, when we take a closer look at the past year, the stock has unfortunately dropped...

Continue Reading
Marco Pharma: 35 Years of Principle Over Profits

Updated Category News Views 3

Keeping Principles Alive in a Competitive Market In an industry where folks often chase the latest trend like seagulls after a fish fry, Marco Pharma International stands its ground on principles rather than profits. It's rare to see a company, especially in the natural health sector, keeping its roots this deep for 35 years. And they're not just talking about it—this...

Continue Reading
Rakovina Therapeutics Unveils AI-Enhanced ATR Inhibitors Breakthrough

Updated Category News Views 188

Rakovina Therapeutics Presents AI-Developed ATR Inhibitors Rakovina Therapeutics Inc. (TSXV: RKV) has made a significant impact at a recent international conference dedicated to cancer therapeutics. The conference gathered numerous leaders in the field, creating an excellent platform to unveil groundbreaking research. Presenting their innovative findings, Rakovina...

Continue Reading
Elon Musk Critiques FCC's Denial of Starlink Subsidy While Aiding Disaster Recovery

Updated Category News Views 334

Elon Musk Critiques FCC's Decision on Starlink Subsidy Elon Musk, the visionary CEO of SpaceX, has voiced his discontent over the FCC's recent ruling that denied approximately $885 million in subsidies to Starlink, the company's satellite internet service. Musk described this decision as "contemptible political lawfare," coinciding with FEMA's deployment of Starlink...

Continue Reading
Assessing the Resilience of American Consumers Amid Challenges

Updated Category News Views 130

Understanding the Current Landscape of American Consumers The state of the American consumer remains resilient despite facing numerous challenges, as reported by Barclays in its recent analysis. The approach to consumer spending in the latest quarter reflects a balancing act, with buyers maneuvering through both advantageous conditions and potential obstacles. Positive...

Continue Reading